Skip to main content

1 Result(s)

within F. Farowski Remove this filter Biomedicine Remove this filter

and

  1. No Access

    Article

    Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension in patients with acute myeloid leukemia or myelodysplastic syndrome

    To estimate the pharmacokinetic (PK) properties of posaconazole in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) undergoing chemotherapy in a clinical setting.

    J. J. Vehreschild, C. Müller, F. Farowski… in European Journal of Clinical Pharmacology (2012)